Home Evaluation of the serum level of CTRP-3 and CTRP-6 in patients with Hashimoto’s disease and correlation with thyroid hormones and lipid profile
Article
Licensed
Unlicensed Requires Authentication

Evaluation of the serum level of CTRP-3 and CTRP-6 in patients with Hashimoto’s disease and correlation with thyroid hormones and lipid profile

  • Rafal Sameer Al-Abboody , Nadia Heydari , Mohsen Saravani , Shahin Nosaratzehi , Hamideh Akbari and Seyyed Mehdi Jafari ORCID logo EMAIL logo
Published/Copyright: January 21, 2025

Abstract

Objectives

Numerous studies show that the adipokines play a role in on the thyroid axis. The aim of this study was the evaluation of serum level of CTRP-3 and CTRP-6 as a member of the adipokines family in patients with Hashimoto’s.

Methods

The levels of CTRP-3 and CTRP-6 were evaluated with enzyme-linked immunosorbent assay in 70 subjects (35 newly diagnosed Hashimoto’s thyroiditis and 35 healthy subjects). Their relationship with the thyroid hormone and some biochemical factors was analyzed.

Results

The levels of CTRP3 and CTRP6 in patients with Hashimoto’s disease were higher than those in the control group (p<0.05). There was a significant positive correlation between CTRP3 and TSH levels (r=0.286 and p=0.017). There was a significant relationship between CTRP3 and Fasting Blood Sugar (r=0.249 and p=0.038). There was a significant inverse negative correlation between CTRP6 levels and T3 (r=−0.269 and p=0.024), and T4 (r=−0.272 and p=0.023). Moreover, there was a significant positive correlation between CTRP6 serum levels and TSH serum levels (r=0.397 and p=0.001). There was a significant positive correlation between CTRP6 levels and Cholesterol (r=0.351 and p=0.003), and LDL (r=−0.244 and p=0.042).

Conclusions

Finally, our results demonstrated that serum levels of CTRP3 and CTRP6 are higher in patients with Hashimoto’s compared to the control group and probably play a role in the pathogenesis of Hashimoto’s thyroiditis.


Corresponding author: Seyyed Mehdi Jafari, PhD, Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran and Department of Biochemistry and Biophysics, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran, E-mail:

Award Identifier / Grant number: 112822

Acknowledgments

This study was obtained from the thesis of Ms. Rafal SamerAL-aboody, a master’s student in clinical biochemistry at Golestan University of Medical Sciences with grant number: 112822.

  1. Research ethics: The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). This study was in agreement with the ethics committee of Golestan University of Medical Sciences that approved the study protocol (IR.GOUMS.REC.1401.151).

  2. Informed consent: Informed consent was obtained from all individuals included in this study, or their legal guardians or wards.

  3. Author contributions: Data collection and draft manuscript: Rafal Samer Al-Aboody. Data analyzing and editing of manuscript: Nadia Hydari Collection of clinical samples: Shahin Nosartzehi, Mohsen Saravani and Hamideh Akbari Study design and Supervision of the research: Seyyed Mehdi Jafari Final version of the manuscript edited and approved by all authors.

  4. Conflict of interest: The authors declare no conflicts of interest.

  5. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  6. Research funding: This study was supported by Golestan University of Medical Sciences with grant number of 112822.

  7. Data availability: The raw data can be obtained on request from the corresponding author.

References

1. Casto, C, Pepe, G, Li Pomi, A, Corica, D, Aversa, T, Wasniewska, M. Hashimoto’s thyroiditis and Graves’ disease in genetic syndromes in pediatric age. Genes 2021;12:222. https://doi.org/10.3390/genes12020222.Search in Google Scholar PubMed PubMed Central

2. Małkowski, B, Serafin, Z, Glonek, R, Suwała, S, Łopatto, R, Junik, R. The role of 18F-FDG PET/CT in the management of the autoimmune thyroid diseases. Front Endocrinol 2019;10:208. https://doi.org/10.3389/fendo.2019.00208.Search in Google Scholar PubMed PubMed Central

3. D’Aurizio, F, Villalta, D, Metus, P, Doretto, P, Tozzoli, R. Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases? Autoimmun Rev 2015;14:363–9. https://doi.org/10.1016/j.autrev.2014.10.008.Search in Google Scholar PubMed

4. Ramos-Leví, AM, Marazuela, M. Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms. Endocrinol Nutr 2016;63:421–9. https://doi.org/10.1016/j.endonu.2016.04.003.Search in Google Scholar PubMed

5. Brown, J, Solomon, D, Beall, G, Terasaki, P, Chopra, I, Van Herle, A, et al.. Autoimmune thyroid diseases—Graves’ and Hashimoto’s. Ann Intern Med 1978;88:379–91. https://doi.org/10.7326/0003-4819-88-3-379.Search in Google Scholar

6. Neumann, E, Lepper, N, Vasile, M, Riccieri, V, Peters, M, Meier, F, et al.. Adipokine expression in systemic sclerosis lung and gastrointestinal organ involvement. Cytokine 2019;117:41–9. https://doi.org/10.1016/j.cyto.2018.11.013.Search in Google Scholar PubMed

7. Schanbacher, C, Hermanns, HM, Lorenz, K, Wajant, H, Lang, I. Complement 1q/tumor necrosis factor-related proteins (CTRPs): structure, receptors and signaling. Biomedicines 2023;11:559. https://doi.org/10.3390/biomedicines11020559.Search in Google Scholar PubMed PubMed Central

8. Choi, HM, Doss, HM, Kim, KS. Multifaceted physiological roles of adiponectin in inflammation and diseases. Int J Mol Sci 2020;21:1219. https://doi.org/10.3390/ijms21041219.Search in Google Scholar PubMed PubMed Central

9. Rasooli Tehrani, A, Gholipour, S, Sharifi, R, Yadegari, S, Abbasi-Kolli, M, Masoudian, N. Plasma levels of CTRP-3, CTRP-9 and apelin in women with multiple sclerosis. J Neuroimmunol 2019;333. https://doi.org/10.1016/j.jneuroim.2019.576968.Search in Google Scholar PubMed

10. Ouchi, N, Parker, JL, Lugus, JJ, Walsh, K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011;11:85–97. https://doi.org/10.1038/nri2921.Search in Google Scholar PubMed PubMed Central

11. Kishore, U, Gaboriaud, C, Waters, P, Shrive, AK, Greenhough, TJ, Reid, KB, et al.. C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol 2004;25:551–61. https://doi.org/10.1016/j.it.2004.08.006.Search in Google Scholar PubMed

12. Ghai, R, Waters, P, Roumenina, LT, Gadjeva, M, Kojouharova, MS, Reid, KB, et al.. C1q and its growing family. Immunobiology 2007;212:253–66. https://doi.org/10.1016/j.imbio.2006.11.001.Search in Google Scholar PubMed

13. Murayama, MA, Chi, HH, Matsuoka, M, Ono, T, Iwakura, Y. The CTRP3-AdipoR2 axis regulates the development of experimental autoimmune encephalomyelitis by suppressing Th17 cell differentiation. Front Immunol 2021;12. https://doi.org/10.3389/fimmu.2021.607346.Search in Google Scholar PubMed PubMed Central

14. Murayama, MA, Kakuta, S, Inoue, A, Umeda, N, Yonezawa, T, Maruhashi, T, et al.. CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis. Nat Commun 2015;6:8483. https://doi.org/10.1038/ncomms9483.Search in Google Scholar PubMed PubMed Central

15. Schmid, A, Vlacil, AK, Schuett, J, Karrasch, T, Schieffer, B, Schäffler, A, et al.. Anti-inflammatory effects of C1q/tumor necrosis factor-related protein 3 (CTRP3) in endothelial cells. Cells 2021;10:2146. https://doi.org/10.3390/cells10082146.Search in Google Scholar PubMed PubMed Central

16. Yang, Y, Li, Y, Ma, Z, Jiang, S, Fan, C, Hu, W, et al.. A brief glimpse at CTRP3 and CTRP9 in lipid metabolism and cardiovascular protection. Prog Lipid Res 2016;64:170–7. https://doi.org/10.1016/j.plipres.2016.10.001.Search in Google Scholar PubMed

17. Komosinska-Vassev, K, Olczyk, P, Kuźnik-Trocha, K, Jura-Półtorak, A, Derkacz, A, Purchałka, M, et al.. Circulating C1q/TNF-related protein 3, omentin-1 and NGAL in obese patients with type 2 diabetes during insulin therapy. J Clin Med 2019;8:805. https://doi.org/10.3390/jcm8060805.Search in Google Scholar PubMed PubMed Central

18. Mohamadinarab, M, Ahmadi, R, Gholamrezayi, A, Rahvar, F, Naghdalipour, M, Setayesh, L, et al.. Serum levels of C1q/TNF-related protein-3 in inflammatory bowel disease patients and its inverse association with inflammatory cytokines and insulin resistance. IUBMB Life 2020;72:1698–704. https://doi.org/10.1002/iub.2293.Search in Google Scholar PubMed

19. Lei, H, Wu, D, Wang, J-Y, Li, L, Zhang, C-L, Feng, H, et al.. C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation. Basic Res Cardiol 2015;110:1–17. https://doi.org/10.1007/s00395-015-0492-7.Search in Google Scholar PubMed

20. Lei, X, Seldin, MM, Little, HC, Choy, N, Klonisch, T, Wong, GW. C1q/TNF-related protein 6 (CTRP6) links obesity to adipose tissue inflammation and insulin resistance. J Biol Chem 2017;292:14836–50. https://doi.org/10.1074/jbc.M116.766808.Search in Google Scholar PubMed PubMed Central

21. Uçar, IMB, Sargin, G, Tuzcu, A, Çildağ, S, Şentürk, T. Correlation of serum subfatin, cthrc1, ctrp3, ctrp6 levels with disease indices in patients with axial spondyloarthritis. BMC Rheumatol 2023;7:29. https://doi.org/10.1186/s41927-023-00356-5.Search in Google Scholar PubMed PubMed Central

22. Tudela, CM, Casey, BM, McIntire, DD, Cunningham, FG. Relationship of subclinical thyroid disease to the incidence of gestational diabetes. Obstet Gynecol 2012;119:983–8. https://doi.org/10.1097/aog.0b013e318250aeeb.Search in Google Scholar

23. Handisurya, A, Pacini, G, Tura, A, Gessl, A, Kautzky‐Willer, A. Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH). Clin Endocrinol 2008;69:963–9. https://doi.org/10.1111/j.1365-2265.2008.03280.x.Search in Google Scholar PubMed

24. Song, Y, Zhao, M, Zhang, H, Zhang, X, Zhao, J, Xu, J, et al.. Thyroid-stimulating hormone levels are inversely associated with serum total bile acid levels: a cross-sectional study. Endocr Pract 2016;22:420–6. https://doi.org/10.4158/ep15844.or.Search in Google Scholar

25. Alsamghan, AS, Alsaleem, SA, Alzahrani, MA, Patel, A, Mallick, AK, Sheweita, SA. Effect of hypovitaminosis D on lipid profile in hypothyroid patients in Saudi Arabia. Oxid Med Cell Longev 2020;2020. https://doi.org/10.1155/2020/6640402.Search in Google Scholar PubMed PubMed Central

26. Peterson, JM, Wei, Z, Wong, GW. C1q/TNF-related protein-3 (CTRP3), a novel adipokine that regulates hepatic glucose output. J Biol Chem 2010;285:39691–701. https://doi.org/10.1074/jbc.m110.180695.Search in Google Scholar PubMed PubMed Central

27. Li, Y, Wright, GL, Peterson, JM. C1q/TNF-related protein 3 (CTRP3) function and regulation. Compr Physiol 2017;7:863. https://doi.org/10.1002/cphy.c160044.Search in Google Scholar PubMed PubMed Central

28. Tabatabaei, S, Fadaei, R, Moradi, N, Farrokhi, V, Vatannejad, A, Afrisham, R, et al.. Circulating levels of C1q/TNF-α-related protein 6 (CTRP6) in coronary artery disease and its correlation with inflammatory markers. J Diabetes Metab Disord 2024:1–9. https://doi.org/10.1007/s40200-024-01415-5.Search in Google Scholar PubMed PubMed Central

29. Caturegli, P, De Remigis, A, Rose, NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev 2014;13:391–7. https://doi.org/10.1016/j.autrev.2014.01.007.Search in Google Scholar PubMed

30. Ralli, M, Angeletti, D, Fiore, M, D’Aguanno, V, Lambiase, A, Artico, M, et al.. Hashimoto’s thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev 2020;19. https://doi.org/10.1016/j.autrev.2020.102649.Search in Google Scholar PubMed

31. Erge, E, Kiziltunc, C, Balci, SB, Atak Tel, BM, Bilgin, S, Duman, TT, et al.. A novel inflammatory marker for the diagnosis of Hashimoto’s thyroiditis: platelet-count-to-lymphocyte-count ratio. Diseases 2023;11. https://doi.org/10.3390/diseases11010015.Search in Google Scholar PubMed PubMed Central

32. Merrill, SJ, Minucci, SB. Thyroid autoimmunity: an interplay of factors. Vitam Horm 2018;106:129–45. https://doi.org/10.1016/bs.vh.2017.07.001.Search in Google Scholar PubMed

33. Huang, X, Zhao, J, Wang, Q, Yan, T, Gou, S, Zhu, X, et al.. Association between plasma CTRPs with cognitive impairment and neurodegeneration of Alzheimer’s disease. CNS Neurosci Ther 2024;30:e14606. https://doi.org/10.1111/cns.14606.Search in Google Scholar PubMed PubMed Central

34. Zhang, A, Kong, M, Zhang, X, Pei, Z. Mechanism of action of CTRP6 in the regulation of tumorigenesis in the digestive system. Oncol Lett 2022;24:391. https://doi.org/10.3892/ol.2022.13511.Search in Google Scholar PubMed PubMed Central

35. Yin, L, Wang, W, Wei, H, Xi, F, Chu, G, Yang, G. Localization and expression of CTRP6 in ovary and its regulation by FSH in porcine granulosa cells. Theriogenology 2019;127:56–65. https://doi.org/10.1016/j.theriogenology.2019.01.009.Search in Google Scholar PubMed

36. Murayama, MA, Kakuta, S, Maruhashi, T, Shimizu, K, Seno, A, Kubo, S, et al.. CTRP3 plays an important role in the development of collagen-induced arthritis in mice. Biochem Biophys Res Commun 2014;443:42–8. https://doi.org/10.1016/j.bbrc.2013.11.040.Search in Google Scholar PubMed

37. Chen, C, Geng, L, Xu, X, Kong, W, Hou, Y, Yao, G, et al.. Comparative proteomics analysis of plasma protein in patients with neuropsychiatric systemic lupus erythematosus. Ann Transl Med 2020;8:579. https://doi.org/10.21037/atm.2020.04.58.Search in Google Scholar PubMed PubMed Central

38. Xue, K, Shao, S, Fang, H, Ma, L, Li, C, Lu, Z, et al.. Adipocyte-derived CTRP3 exhibits anti-inflammatory effects via LAMP1-STAT3 axis in psoriasis. J Invest Dermatol 2022;142:1349–59.e8. https://doi.org/10.1016/j.jid.2021.09.027.Search in Google Scholar PubMed

39. Chen, L, Cui, M. GW29-e0935 changes and clinical significance of plasma levels of new adipokines CTRP3 in patients with atrial fibrillation. J Am Coll Cardiol 2018;72:C145–C. https://doi.org/10.1016/j.jacc.2018.08.671.Search in Google Scholar

40. Chen, L, Liu, S, Xu, W, Zhang, Y, Bai, J, Li, L, et al.. Association of plasma C1q/TNF-related protein 3 (CTRP3) in patients with atrial fibrillation. Mediat Inflamm 2020;2020. https://doi.org/10.1155/2020/8873152.Search in Google Scholar PubMed PubMed Central

41. Li, Y, Sun, J, Gu, L, Gao, X. Protective effect of CTRP6 on cerebral ischemia/reperfusion injury by attenuating inflammation, oxidative stress and apoptosis in PC12 cells. Mol Med Rep 2020;22:344–52. https://doi.org/10.3892/mmr.2020.11108.Search in Google Scholar PubMed PubMed Central

42. Wei, C, Liu, Y, Xing, E, Ding, Z, Tian, Y, Zhao, Z, et al.. Association between novel pro-and anti-inflammatory adipocytokines in patients with acute coronary syndrome. Clin Appl Thromb/Hemost 2022;28. https://doi.org/10.1177/10760296221128021.Search in Google Scholar PubMed PubMed Central

43. Tomov, DG, Levterova, BA, Troev, DM, Miteva, MZ, Mihaylova, VN, Uzunova, YI, et al.. Serum levels of leptin and adiponectin in patients with autoimmune Hashimoto’s thyroiditis. Folia Med 2023;65:199–206. https://doi.org/10.3897/folmed.65.e75390.Search in Google Scholar PubMed

44. Siemińska, L, Wojciechowska, C, Kos-Kudła, B, Marek, B, Kajdaniuk, D, Nowak, M, et al.. Serum concentrations of leptin, adiponectin, and interleukin-6 in postmenopausal women with Hashimoto’s thyroiditis. Endokrynol Pol 2010;61:112–6.Search in Google Scholar

45. Delitala, AP, Steri, M, Fiorillo, E, Marongiu, M, Lakatta, EG, Schlessinger, D, et al.. Adipocytokine correlations with thyroid function and autoimmunity in euthyroid sardinians. Cytokine 2018;111:189–93. https://doi.org/10.1016/j.cyto.2018.08.027.Search in Google Scholar PubMed PubMed Central

46. Altinova, AE, Toruner, F, Karakoc, A, Yetkin, I, Ayvaz, G, Cakir, N, et al.. Serum ghrelin levels in patients with Hashimoto’s thyroiditis. Thyroid 2006;16:1259–64. https://doi.org/10.1089/thy.2006.16.1259.Search in Google Scholar PubMed

47. Cinar, N, Gurlek, A. Association between novel adipocytokines adiponectin, vaspin, visfatin, and thyroid: an experimental and clinical update. Endocr Connect 2013;2:R30–8. https://doi.org/10.1530/ec-13-0061.Search in Google Scholar PubMed PubMed Central

48. Iglesias, P, Díez, JJ. Influence of thyroid dysfunction on serum concentrations of adipocytokines. Cytokine 2007;40:61–70. https://doi.org/10.1016/j.cyto.2007.10.001.Search in Google Scholar PubMed

49. Choi, KM, Hwang, SY, Hong, HC, Choi, HY, Yoo, HJ, Youn, BS, et al.. Implications of C1q/TNF-related protein-3 (CTRP-3) and progranulin in patients with acute coronary syndrome and stable angina pectoris. Cardiovasc Diabetol 2014;13:14. https://doi.org/10.1186/1475-2840-13-14.Search in Google Scholar PubMed PubMed Central

50. Demirtas, D, Acıbucu, F, Baylan, FA, Gulumsek, E, Saler, T. CTRP3 is significantly decreased in patients with primary hyperparathyroidism and closely related with osteoporosis. Exp Clin Endocrinol Diabetes 2020;128:152–7. https://doi.org/10.1055/a-0899-5210.Search in Google Scholar PubMed

51. Trogen, G, Alamian, A, Peterson, JM. High molecular weight, but not total, CTRP3 levels are associated with serum triglyceride levels. Phys Rep 2019;7:e14306. https://doi.org/10.14814/phy2.14306.Search in Google Scholar PubMed PubMed Central

52. Xu, ZH, Zhang, X, Xie, H, He, J, Zhang, WC, Jing, DF, et al.. Serum CTRP3 level is associated with osteoporosis in postmenopausal women. Exp Clin Endocrinol Diabetes 2018;126:559–63. https://doi.org/10.1055/s-0043-124365.Search in Google Scholar PubMed

53. Elsaid, HH, Elgohary, MN, Elshabrawy, AM. Complement c1q tumor necrosis factor-related protein 3 a novel adipokine, protect against diabetes mellitus in young adult Egyptians. Diabetes Metab Syndr 2019;13:434–8. https://doi.org/10.1016/j.dsx.2018.10.004.Search in Google Scholar PubMed

54. Sadeghi, A, Fadaei, R, Moradi, N, Fouani, FZ, Roozbehkia, M, Zandieh, Z, et al.. Circulating levels of C1q/TNF-α-related protein 6 (CTRP6) in polycystic ovary syndrome. IUBMB Life 2020;72:1449–59. https://doi.org/10.1002/iub.2272.Search in Google Scholar PubMed

55. Iftikhar, U, Iqbal, A, Shakoor, S. Relationship between leptin and lipids during pre-eclampsia. J Pak Med Assoc 2010;60:432–5.Search in Google Scholar

56. Rafieian-Kopaei, M, Nasri, H. Association of serum lipids with levels of leptin in hemodialysis patients. J Nephropharmacol 2013;2:17–20.Search in Google Scholar

Received: 2024-04-17
Accepted: 2024-12-20
Published Online: 2025-01-21

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 3.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2024-0060/html
Scroll to top button